Status:
COMPLETED
GnRH-a on Angiogenesis of Endometriosis
Lead Sponsor:
University of Patras
Conditions:
Angiogenesis
Endometriosis
Eligibility:
FEMALE
32-42 years
Phase:
NA
Brief Summary
Purpose: Neo-angiogenesis is necessary for adhesion and invasiveness of endometriotic lesions in women affected by endometriosis. VEGF is one of the major components of angiogenesis and is part of the...
Detailed Description
The subjects in this study were women of reproductive age. From September 2015 to December 2022, sixty women with known endometriosis \[stage 2 and 3\], were recruited. Their mean age was 38 years. Th...
Eligibility Criteria
Inclusion
- reproductive age.
- endometriosis \[stage 2 and 3\]
- nulliparous
Exclusion
- women who received any hormonal treatment within the 12 months before the surgical procedure
- obesity BMI\>32kg/m2
Key Trial Info
Start Date :
September 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06106932
Start Date
September 1 2015
End Date
January 1 2023
Last Update
October 30 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Patras University School of Medicine
Patra, Peloponnese, Greece, 26504
2
Tottori University Faculty of Medicine
Yonago, Tottori, Japan, 683-8503